TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,293,169 | -41.8% | 513,537 | +73.0% | 0.00% | -40.0% |
| Q2 2023 | $7,374,672 | +8.2% | 296,887 | -34.5% | 0.01% | 0.0% |
| Q1 2023 | $6,817,662 | -7.2% | 453,302 | -27.0% | 0.01% | -16.7% |
| Q4 2022 | $7,343,484 | -28.6% | 620,751 | -64.3% | 0.01% | -25.0% |
| Q3 2022 | $10,287,000 | +89.6% | 1,737,752 | +36.1% | 0.01% | +100.0% |
| Q2 2022 | $5,425,000 | +461.6% | 1,276,508 | +1157.6% | 0.00% | +300.0% |
| Q1 2022 | $966,000 | -94.6% | 101,501 | -89.2% | 0.00% | -88.9% |
| Q4 2021 | $17,800,000 | +555.1% | 936,821 | +1047.2% | 0.01% | +350.0% |
| Q3 2021 | $2,717,000 | -39.3% | 81,664 | -29.2% | 0.00% | -33.3% |
| Q2 2021 | $4,478,000 | +1.7% | 115,421 | +26.4% | 0.00% | 0.0% |
| Q1 2021 | $4,401,000 | -18.1% | 91,307 | -11.6% | 0.00% | -25.0% |
| Q4 2020 | $5,372,000 | +99.9% | 103,246 | +2.8% | 0.00% | +300.0% |
| Q3 2020 | $2,687,000 | -21.0% | 100,410 | -42.5% | 0.00% | -50.0% |
| Q2 2020 | $3,402,000 | +82.4% | 174,602 | -7.9% | 0.00% | 0.0% |
| Q1 2020 | $1,865,000 | -30.2% | 189,622 | -21.2% | 0.00% | 0.0% |
| Q4 2019 | $2,671,000 | +39.9% | 240,729 | -29.2% | 0.00% | +100.0% |
| Q3 2019 | $1,909,000 | -47.0% | 339,870 | -18.4% | 0.00% | -50.0% |
| Q2 2019 | $3,605,000 | +1026.6% | 416,714 | +944.2% | 0.00% | – |
| Q1 2019 | $320,000 | -85.8% | 39,907 | -92.7% | 0.00% | -100.0% |
| Q4 2018 | $2,252,000 | +91.8% | 549,373 | +162.2% | 0.00% | +100.0% |
| Q3 2018 | $1,174,000 | -10.3% | 209,495 | +110.6% | 0.00% | 0.0% |
| Q2 2018 | $1,309,000 | -0.2% | 99,458 | +7.6% | 0.00% | 0.0% |
| Q1 2018 | $1,312,000 | +23.8% | 92,445 | -28.5% | 0.00% | 0.0% |
| Q4 2017 | $1,060,000 | -7.0% | 129,251 | +34.3% | 0.00% | 0.0% |
| Q3 2017 | $1,140,000 | +31.0% | 96,215 | +11.2% | 0.00% | 0.0% |
| Q2 2017 | $870,000 | +21650.0% | 86,512 | +24688.5% | 0.00% | – |
| Q1 2017 | $4,000 | – | 349 | +249.0% | 0.00% | – |
| Q4 2016 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -99.6% | 100 | -99.7% | 0.00% | – |
| Q1 2016 | $249,000 | +465.9% | 29,273 | +694.8% | 0.00% | – |
| Q4 2015 | $44,000 | -89.2% | 3,683 | -90.9% | 0.00% | – |
| Q3 2015 | $407,000 | +4422.2% | 40,352 | +7645.1% | 0.00% | – |
| Q2 2015 | $9,000 | -75.0% | 521 | -77.1% | 0.00% | – |
| Q1 2015 | $36,000 | -58.1% | 2,272 | -57.7% | 0.00% | – |
| Q4 2014 | $86,000 | +855.6% | 5,374 | +557.8% | 0.00% | – |
| Q3 2014 | $9,000 | +350.0% | 817 | +312.6% | 0.00% | – |
| Q2 2014 | $2,000 | -90.0% | 198 | -93.2% | 0.00% | – |
| Q1 2014 | $20,000 | 0.0% | 2,918 | -44.4% | 0.00% | – |
| Q4 2013 | $20,000 | +566.7% | 5,245 | +737.9% | 0.00% | – |
| Q3 2013 | $3,000 | -40.0% | 626 | -12.0% | 0.00% | – |
| Q2 2013 | $5,000 | – | 711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |